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Abstract
Background: Selectin mediated tethering represents one of the earliest steps in T cell extravasation into lymph nodes via
high endothelial venules and is dependent on the biosynthesis of sialyl Lewis X (sLe
x) ligands by several
glycosyltransferases, including two fucosyltransferases, fucosyltransferase-IV and –VII. Selectin mediated binding also plays
a key role in T cell entry to inflamed organs.
Methodology/Principal Findings: To understand how loss of selectin ligands (sLe
x) influences T cell migration to the lung, we
examined fucosyltransferase-IV and –VII double knockout (FtDKO) mice. We discovered that FtDKO mice showed significant
increases (,5-fold) in numbers of naı ¨ve T cells in non-inflamed lung parenchyma with no evidence of induced bronchus-
associated lymphoid tissue. In contrast, activated T cells were reduced in inflamed lungs of FtDKO mice following viral infection,
consistent with the established role of selectin mediated T cell extravasation into inflamed lung. Adoptive transfer of T cells into
FtDKO mice revealed impaired T cell entry to lymph nodes, but selective accumulation in non-lymphoid organs. Moreover,
inhibition of T cell entry to the lymph nodes by blockade of L-selectin, or treatment of T cells with pertussis toxin to inhibit
chemokine dependent G-coupled receptor signaling, also resulted in increased T cells in non-lymphoid organs. Conversely,
inhibition of T cell egress from lymph nodes using FTY720 agonism of S1P1 impaired T cell migration into non-lymphoid organs.
Conclusions/Significance: Taken together, our results suggest that impaired T cell entry into lymph nodes via high
endothelial venules due to genetic deficiency of selectin ligands results in the selective re-distribution and accumulation of
T cells in non-lymphoid organs, and correlates with their increased frequency in the blood. Re-distribution of T cells into
organs could potentially play a role in the initiation of T cell mediated organ diseases.
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Introduction
Lymphocytes are highly migratory cells. Uncovering pathways
that allow these cells to access tissues not only facilitates our
understanding of cell migration, but deepens our understanding of
the relationship between immunity and immunopathology. Blood
borne leukocytes, such as T lymphocytes, are recruited to extra-
vascular sites, and these processes are highly regulated so that
distinct cell populations are delivered to intended site(s) in the
proper physiological or pathological context (reviewed in [1,2,3]).
Imperfections in these processes may lead to qualitatively or
quantitatively inappropriate delivery of cells to tissue sites that may
result in inflammatory pathological processes (reviewed in [3]).
Several leukocyte adhesion deficiency (LAD) diseases in humans
have been described, including LAD II, a congenital immunode-
ficiency disease characterized by patients having defective
production of fucosylated ligands necessary for selectin mediated
tethering [4,5,6,7].
Selectins (E-selectin, P-selection, and L-selectin) are type I
transmembrane glycan binding proteins (GBPs), or C-type lectins,
that regulate leukocyte-endothelial cell adhesive interactions,
critically involved in T lymphocyte trafficking from the blood to
extra-vascular compartments [3]. Selectins interact selectively with
sialylated fucosylated lactosamine structures (sialyl Lewis x or sLe
x)
of membrane-associated mucin type glycoproteins such as Gly-
CAM-1, CD34, and MAdCAM-1 via binding by amino terminal
carbohydrate recognition domains (CRDs). The a1, 3 fucosyltrans-
ferases catalyze the synthesis of the sLe
x moiety, and thus these
enzymes are essential in the elaboration of selectin ligands, although
additional modification by sulfotransferases contributes to L-selectin
binding [8,9,10,11]. Naı ¨ve and central memory T lymphocytes
express leukocyte selectin, or L-selectin, while activated T
lymphocytes downregulate L-selectin, but begin to express E- and
P- selectin ligands as a consequence of inducible expression of a1, 3
fucosyltransferases [12,13,14]. High endothelial cells which line
functionally distinct high endothelial venules (HEVs) in different
lymph nodes, constitutively express a1, 3 fucosyltransferases, and
this allows shear-dependent adhesive interactions between lympho-
cytes and selectin ligands on HEVs [15,16]. Following initial
selectin-mediated tethering of T cells, chemokine receptor binding
of chemokines, such as CCR7 binding CCL21, activates G-coupled
receptor signaling, which induces a conformational change of T cell
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cells leads to firm arrest and facilitates transendothelial migration
into the lymph node (LN) [17,18].
Mice lacking the a1, 3 fucosyltransferases were generated several
years ago and demonstrate loss of selectin binding activity, impaired
T cell migration to draining lymph nodes but normal migration to
spleen, as well as impaired T cell extravasation to skin in both
contact hypersensitivity and viral models [12,19]. However,
knockout mice of one or both enzymes are able to mount potent
immune responses as evidenced by clearance of lymphocytic
choriomeningitis virus (LCMV), vesicular stomatitis virus (VSV),
and vaccinia viral infection in brain and ovaries, despite reduction
of lymph node T cell numbers [12,19,20]. Moreover, examination
of fucosyltransferase-VII and-IV double knockout mice (FtDKO)
for immunity following infection with Mycobacterium tuberculosis found
that FtDKO mice had significantly diminished numbers of
activated CD8 and CD4 T cells in the draining lymph node of
the lung (mediastinal lymph node, MedLN), but had effective
granuloma responses and similar recruitment of activated T cells
into the lung at later stages of infection [21]. Importantly,
Mycobacterium tuberculosis infection of FtDKO mice demonstrated
that iBALT develops similarly in the lungs of FtDKO mice, and
express CXCL13, CCL21, and CCL19 chemokines [21]. This
reduction in T cells in the MedLN of FtDKO mice, even under
conditions of chronic inflammation by an intracellular pathogen,
convincingly suggests that no major alternative mechanism of cell
recruitment compensates for the deficiency of a1, 3 fucosyltrans-
ferases in T cell homing to the LN [21].
We were interested in determining how loss of selectin ligands
affects immunity at mucosal sites [22]. Here we report our discovery
that FtDKO mice display a significant increase in naı ¨ve T cell
populations located in the lung. This phenotype has never been
reported in these mice, so we further explored the contribution of
selectin ligands to T cell migration into non-lymphoid organs. We
examinedTcelltraffickinginFtDKOmiceundernon-inflammatory
conditions, as well as following inflammation due to viral infection.
The data presented here suggests that in FtDKO mice, T cells
selectively accumulate in non-lymphoid organs under non-inflam-
matory conditions. However, under inflammatory conditions, T cell
trafficking of Ag-specific effector and memory T cell populations to
non-lymphoid organs was reduced in FtDKO mice, consistent with
previous studies [23,24,25]. Finally, to investigate why naı ¨ve T cells
would preferentially accumulate in non-lymphoid organs of FtDKO
mice under non-inflammatory conditions, we considered two
explanations—1) a specific increase in trafficking due to loss of
selectinligandexpressioninthelungs of FtDKO,making them more
permissive to T cell entry, or 2) a non-specific increase in trafficking
to non-lymphoid organs due to T cell re-distribution when cells
cannot enter LNs. We tested the latter hypothesis and our results are
consistent with this hypothesis. Treatments that block T cell entry
into the LN result in selectively increased numbers of T cells in non-
lymphoid organs. Conversely, treatments that blocked T cell exit
from the LN showed reduced T cell trafficking to non-lymphoid
organs. Thus, under conditions where T cell entry to LNs is
impaired, T cells may accumulate in the perivascular or interstitial
compartments of the lung, and this altered distribution could
possibly play a role in the initiation of lung diseases.
Results
Increased numbers of naı ¨ve T cells in the lungs of FtDKO
mice
We isolated lymphocytes from organs of naı ¨ve WT and FtDKO
mice and analyzed CD4 and CD8 T populations at each site. As
expected, CD4 and CD8 T cell populations were significantly
reduced (,70%) in mediastinal lymph node (MedLN) (Figure 1A,
C). CD8 T cell populations were also reduced in the organized
nasal associated lymphoid tissue (O-NALT). Surprisingly, we
observed ,5-fold increase in T cell numbers in the lungs of
FtDKO mice, and we also consistently observed a modest increase
in T cell numbers in the spleen (,20% increase) (Figure 1A, C). B
cell populations were also increased in the lung, about 2-fold (data
not shown). Phenotypic analysis of T cell populations in organs of
the FtDKO mice reveal that similar to WT mice, the majority of T
cells in the spleen and lung were naı ¨ve (CD44
lo and CD62L
high)
(Figure 1B and data not shown). However, in the MedLN and O-
NALT of FtDKO mice, there was a significant decrease in naı ¨ve
(CD44
lo) T cell populations (Figure 1B, D).
Since we saw increased numbers of T cells in the lungs of
FtDKO mice, we hypothesized that similar to CCR7-/- mice,
FtDKO mice may show evidence of neo-lymphoid follicles or
induced bronchus-associated lymphoid tissue (iBALT) in the lungs
[26]. However, H&E analysis of lung sections from FtDKO
showed no evidence of iBALT in any lung sections examined
(Figure 1E). Analysis of T cells in lung sections suggested increased
T cells in the perivascular compartment, consistent with the
observed increase in T cell numbers by FACS analysis (Figure 1F).
Taken together, these observations raised the possibility that naı ¨ve
T cells in FtDKO mice were re-distributing to other organs,
including non-lymphoid organs such as the lung.
Migration of Ag-specific CD8 T cells to inflamed lung is
impaired in FtDKO mice
The role of selectin mediated recruitment of leukocytes to
inflamed tissues is well established [23,24,27]. Following inflam-
matory insult, E- and P-selectin are upregulated on inflamed
endothelial cells allowing for the recruitment of selectin ligand
expressing leukocytes. Naı ¨ve T cells express L-selectin, but not
selectin ligands, while activated T cells downregulate L-selectin,
both transcriptionally and via proteolytic cleavage, and induce
expression of a1, 3 fucosyltransferases, resulting in selectin ligand
expression [14,28,29,30].
We examined the expansion of Ag-specific effector and memory
CD8 T cell populations in the lungs of WT and FtDKO mice
following LCMV Armstrong infection. At day 8 and day 60 post-
infection, we observed significant expansion of viral specific CD8
T cells in organs of FtDKO mice (Figure 2A, B). However, CD8 T
cell numbers were significantly reduced (,50%) in the lungs of
FtDKO mice compared to WT mice, consistent with the described
role of selectin-mediated homing to inflamed lung (Figure 2C, D).
Similar to a recent study, CD8 T cell numbers in the MedLN
following infection remained severely reduced (,85%, Figure 2C,
D) [21]. Interestingly, we noted that at day 60, Ag-specific
memory CD8 T cells in MedLN and O-NALT were not reduced
(Figure 2B, D). In fact, FtDKO LN showed significant enrichment
of Ag-specific memory CD8 T cells compared to the total CD8
population (Figure 2 and J. R. Harp and T. M. Onami manuscript
in preparation).
Naı ¨ve and memory T cells preferentially accumulate in
non-lymphoid organs in FtDKO mice
Paradoxically, our results following infection show that effector
and memory Ag-specific CD8 T cell populations were reduced in
the inflamed lungs of FtDKO mice, while naı ¨ve CD8 populations
were increased in the lungs of uninfected FtDKO mice (Figures 1
and 2). Previously published studies have shown that defective T
cell migration to inflamed lungs was due to loss of expression of
T Cells Re-Distribute to Lung
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e10973selectin ligands by T cells—i.e. defective migration to inflamed
tissues in FtDKO mice is T cell intrinsic [25]. However, defective
T cell migration to LNs is due to loss of expression of selectin
ligands on HEVs [16,25]. In FtDKO mice, selectin ligand
expression is absent in all cells, including activated T cells.
To determine whether naı ¨ve or memory CD8 T cells, capable
of expressing selectin ligands, selectively homed to the lung of
FtDKO mice, we performed adoptive transfer of bona fide P14.Tg
WT naı ¨ve and central memory CD8 T cells into WT or FtDKO
recipient mice under non-inflammatory conditions. As expected,
transferred T cells were significantly impaired in homing to LNs as
well as O-NALT in FtDKO mice (Figure 3B). In contrast, we
observed that transferred naı ¨ve and memory CD8 T cells show
increased numbers in the spleen, lung, and liver of FtDKO mice
compared to WT mice (Figure 3B, C). We saw no evidence of
transferred T cells in the bronchial alveolar lavage (BAL) (data not
shown). The majority of transferred CD8 T cell populations were
located in the spleens of both WT and FtDKO mice (79% and
82% respectively). The remaining CD8 T cells show differences in
their distribution comparing blood, liver, lung, cervical lymph
node (CLN), iliac lymph node (ILN), and MedLN (Figure 3C). In
WT recipient mice, the majority of the remaining transferred CD8
T cells preferentially homed to the LNs with a small fraction in
non-lymphoid organs (Figure 3C). In contrast, in FtDKO mice,
the majority of the remaining transferred CD8 T cells were
preferentially located in the lung and liver, with few entering the
LNs (Figure 3C). Thus, consistent with our observation of
increased numbers of naı ¨ve T cells in non-lymphoid organs of
FtDKO mice, these data demonstrated that naı ¨ve and central
memory CD8 T cells preferentially accumulated in non-lymphoid
organs in FtDKO mice.
Inhibition of naı ¨ve T cell trafficking to LN by Pertussis
toxin treatment results in selective re-distribution to non-
lymphoid organs
The observation of increased numbers of T cells in the lungs
of FtDKO mice could be due to several possibilities. One
Figure 1. Increased numbers of naı ¨ve T cells in lungs of FtDKO mice. Lymphocytes were isolated from WT and FtDKO mice. A and B,
Representative FACS analysis of organs from WT or FtDKO mice. Cells were stained with CD4, CD8 and CD44 mAbs. Numbers indicate percent of CD4,
CD8, or CD44
Lo CD8 T cells. C, Enumeration of CD8 and CD4 T cells in indicated organs. D, Enumeration of CD44
Lo CD8 or CD44
Lo CD4 T cells in
indicated organs. E, Photomicrographs of representative H & E staining of WT and FtDKO lungs at 640 magnification. F. Photomicrographs of
representative immuno-histology staining of T cells using Thy1 of WT and FtDKO lungs at6200 magnification. Data was collected from n=6 WT and
n=7 FtDKO in two independent experiments. For O-NALT, one experiment is shown where cells were pooled from n=4 mice/group. The unpaired
Student t test was used to compare groups. (*p,0.05, ** p,0.01, and *** p,0.001).
doi:10.1371/journal.pone.0010973.g001
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mice results in a change in the lung environment, making the
lung more permissive for T cell entry. A recent report observed
that reduced sLe
x expression on lung epithelial cells contributes
to defects in airway wound repair [31]. Additionally, defects in
core fucosylation have been associated with abnormal lung
development and an emphysema-like phenotype in Fut8
deficient mice [32,33]. Another possibility is that by blocking
T cell entry to the LN, T cells are re-distributed to other sites.
Naı ¨ve T cells may end up in non-lymphoid organs, if these sites
are part of the normal migratory pathway of naı ¨ve T cells
[34,35,36]. To test this hypothesis, we examined whether
inhibition of chemokine receptor signaling by pertussis toxin
treatment (Ptx) also results in increased migration of naı ¨ve CD8
T cells to lung and other non-lymphoid organs of recipient mice.
In Figure 4, we show that as expected, Ptx treatment of naı ¨ve
CD8 T cells resulted in significantly impaired trafficking of
transferred T cells to LNs, observed as decreased percentages
and overall numbers of transferred Thy1.1 cells in CLN, ILN,
and MedLN (Figure 4B, C). In contrast, significantly more naı ¨ve
CD8 T cells were observed in the lung and liver (Figure 4C). We
observed no differences in numbers of transferred naı ¨ve CD8 T
cells in spleen and bone marrow. Notably, we observed an
increased concentration of transferred Ptx treated T cells in the
blood (Figure 4C). Additionally, as shown later, if we treated
recipient mice with blocking antibodies to L-selectin (anti-
CD62L), we also observed reductions in naı ¨ve CD8 T cells in
LNs, and increased T cells in lung and liver. Taken together,
these data support our hypothesis that general inhibition of T
cell trafficking to LN results in increased T cell re-distribution to
non-lymphoid organs.
Retention of T cells in LN by FTY720 treatment results in
reduced naı ¨ve CD8 T cell populations in non-lymphoid
organs
Thus far, our experiments demonstrated that when we inhibited
entry of naı ¨ve CD8 T cells via HEVs to LNs, we observed
increases in the number of T cells in lung and liver (Figure 3–4).
Based on this result, we predicted that if we blocked T cell egress
from the LN, we should observe reduced T cells in the lung and
liver. To test this hypothesis, we transferred naı ¨ve CD8 T cells into
recipient mice, and treated these mice with FTY720, an agonist
for S1P1, which inhibits T cell egress from the LN [37,38].
Treatment with FTY720 generally resulted in increased total
lymphocytes in LNs and a significant drop in total lymphocytes in
Figure 2. Ag-specific CD8 T cells are reduced in inflamed lung of FtDKO mice. WT or FtDKO mice were infected with LCMV-Armstrong i.p
and lymphocytes were isolated on day 8 or day 60 p.i. A, Representative FACS analysis of single cell suspensions from indicated organs on day 8 p.i.
Cells were stained with CD8, CD44 and DbNP396-404 tetramer. Gating on CD8 T cells, numbers in FACS panels indicate percent of Ag-specific CD8 T
cells in organs. B, Representative FACS analysis of single cell suspensions from indicated organs on day 60 p.i. Cells were stained with CD8, CD44 and
DbGP33-41 tetramer. C, Enumeration of Ag-specific, CD44
high, and total CD8 T cells in WT or FtDKO mice at day 8. D, Enumeration of Ag-specific,
CD44
high, and total CD8 T cells in WT or FtDKO mice at day 60. For day 8, n=2 WT and n=3 FtDKO. For day 60, n=4 WT and n=4 FtDKO. For O-NALT,
organs were pooled from each group. (*p,0.05, ** p,0.01, and *** p,0.001).
doi:10.1371/journal.pone.0010973.g002
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transferred naı ¨ve CD8 T cell population revealed that transferred
T cells in treated mice were significantly lower in the liver, lung,
and PBMC while remaining unchanged in other organs
(Figure 5D). Our study using bone fide naı ¨ve T cells supports and
extends data in a recent paper showing FTY720 treatment
depletes endogenous naı ¨ve phenotype T cells in peripheral organs
[38].
Figure 3. T cells preferentially accumulate in non-lymphoid organs of FtDKO mice. CD8 T cells were purified from naı ¨ve Thy1.1xP14 Tg
mice (CFSE
+) or immune (day 200 p.i.) Thy1.1xP14 Tg chimeric mice (CFSE
-), transferred into WT or FtDKO recipient mice, and recipient mice were
sacrificed 18 hours later. Thy1.1 was used to differentiate endogenous from transferred T cell populations from indicated organs. A, Experimental
design and phenotype of transferred cell populations. B, Enumeration of transferred CD8 T cell populations in indicated organs. C, Pie charts showing
the distribution of Thy1.1 cells in WT and FtDKO recipient mice in spleen, PBMC, liver, lung, CLN, ILN, and MedLN. Of the indicated organs, ,80% of
transferred cells are located in spleen. The smaller pie chart shows the distribution of the remaining transferred cells. Data was collected from n=5
WT and n=6 FtDKO from two independent experiments. (*p,0.05, ** p,0.01, and *** p,0.001).
doi:10.1371/journal.pone.0010973.g003
T Cells Re-Distribute to Lung
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T cells in blood
If we focused our analysis on naı ¨ve CD8 T cells, a clear inverse
relationship emerges from our data (Figure 6). We used several
methods to block T cell entry to LN, including genetic ablation of
selectin ligands (FtDKO mice), inhibition of G-coupled dependent
chemokine receptor signaling in T cells, or anti-CD62L treatment
of mice to inhibit CD62L dependent migration (Figure 6). In
general, under conditions of impaired migration to LN, we
observed increased migration to non-lymphoid organs such as lung
and liver (Figure 6A). In contrast, S1P1 agonism by FTY720
treatment of mice results in retention of transferred naı ¨ve CD8 T
cells in LN, but resulted in a drop in naı ¨ve T cells in non-lymphoid
organs (Figure 6A). Taken together, the proportion of naı ¨ve T cells
located in non-lymphoid organs was inversely correlated with the
proportion of naı ¨ve T cells in the LN (Figure 6A).
Under normal conditions naı ¨ve T cells emerge from the thymus
and migrate via the circulation into secondary lymphoid organs
and exit LNs via the lymphatic vessels, culminating at the thoracic
duct, which drains into the superior vena cava, returning T cells to
the blood. We reasoned that treatments that inhibit naı ¨ve T cells
in the blood from entering the LN via HEVs would result in higher
proportions of naı ¨ve T cells remaining in the blood. This higher
proportion of T cells in the blood could result in higher numbers of
T cells that transit into the lung via the lung’s dual blood supplies,
the pulmonary and bronchial arteries, where T cells could
accumulate in the lung perivascular and interstitial compartments
[34,39]. However, in the mouse it is generally agreed that there is
limited blood supply from the bronchial arteries, so the pulmonary
arteries are the only blood supply to the lung, and T cells may
enter lung compartments after being sequestered in the pulmonary
capillary bed [40,41,42]. Conversely, treatments that retain T cells
in the LN could reduce the proportion of T cells in the blood,
limiting the number of T cells that may potentially enter the lung.
We analyzed the proportion of transferred naı ¨ve CD8 T cells in
the blood following inhibition of LN entry, or inhibition of LN exit.
For each treatment, we calculated the ratio of the concentration of
naı ¨ve T cells inthe blood in treatedversusuntreated groups of mice.
We then considered whether this resulted in more T cells in LN or
non-lymphoid organs. Schematically, we show that there is an
inverse relationship between the concentration of naı ¨ve T cells in
the blood and localization in LN versus non-lymphoid organs
Figure 4. Inhibition of T cell trafficking to LN by pertussis toxin treatment results in selective re-distribution of naı ¨ve T cells to non-
lymphoid organs. Splenocytes from Thy1.1xP14 Tg mice were treated with either pertussis toxin (Ptx) or PBS control and transferred into WT
recipient mice. 18 hours post transfer, T cells were isolated from indicated organs and analyzed by FACS. A, Experimental design. B, Representative
FACS analysis of indicated organs gating on CD8 T cells. Numbers indicate percentage of transferred cells in the indicated organ. FACS panels from
animals that received untreated cells, Ptx-treated cells, or received no transferred cells are shown. C, Enumeration of transferred cells in organs. Data
was analyzed from n=3 control untreated and n=4 Ptx treated groups. (*p,0.05, ** p,0.01, and *** p,0.001)
doi:10.1371/journal.pone.0010973.g004
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LN, via the HEVs using CD62L antibody blockade, genetic
deficiency of selectin ligands, or inhibition of chemokine receptor
signaling via G-coupled receptor signaling pathways, we observed
more naı ¨ve CD8 T cells in the blood, and we also observed more
naı ¨ve CD8 T cells in non-lymphoid organs (Figure 6B). Conversely,
when we inhibited naı ¨ve CD8 T cell exit from the LN, via S1P1
agonism, fewer naı ¨ve CD8 T cells were observed in the blood, and
we observed fewer naı ¨ve CD8 T cells in non-lymphoid organs
(Figure 6B). Under homeostatic conditions, the majority of naı ¨ve T
cells preferentially home from the blood via HEVs into the LN, and
we observe a small, but measurable population of naı ¨ve T cells in
non-lymphoid organs (Figure 1 and 6). Thus, our observation of
increased naı ¨ve T cells in the lungs of FtDKO mice is consistent
with our hypothesis that impaired T cell migration to secondary
lymphoid organs such as LN, results in increased T cells in the
blood, and subsequently results in migration and preferential
accumulation in non-lymphoid organs.
Discussion
The focal event of the adaptive immune response is the
encounter between naı ¨ve T cells and APCs displaying specific
antigen, which results in T cell activation. Thus, our understand-
ing of the immune system will be critically dependent on
characterizing the molecular events that regulate and guide highly
migratory T cells and APCs to appropriate microenvironments
[43]. In this study, we have discovered a previously unknown
phenotype in FtDKO mice. We observed increased numbers of
naı ¨ve T cells in the lungs with no evidence of iBALT formation,
and we demonstrated that T cells selectively re-distribute to the
lung, as well as several other organs in FtDKO mice (Figure 1, 3).
Viral infection of FtDKO mice to induce inflammation and trigger
viral-specific T cell expansion, demonstrated that while there was
robust CD8 T cell expansion and viral clearance by day 8, Ag-
specific effector and memory CD8 T cell populations were
significantly reduced in the lungs of FtDKO mice, consistent with
the described role of selectin ligands in T cell extravasation to
inflamed organs (Figure 2 and data not shown). Taken together,
our data suggests that both selectin ligand-dependent and selectin
ligand-independent mechanisms contribute to T cell migration to
non-lymphoid organs under inflammatory and non-inflammatory
conditions, respectively.
To further understand the mechanism of T cell re-distribution
and accumulation in non-lymphoid organs under non-inflamma-
tory conditions, we transferred bona fide naı ¨ve and memory CD8 T
Figure 5. Retention of naı ¨ve T cells in LN by FTY720 treatment depletes naı ¨ve T cell populations in non-lymphoid organs. Splenocytes
from naı ¨ve Thy1.1xP14 Tg mice were adoptively transferred into WT recipient. Recipient mice were treated for three days with FTY720 and lymphocytes
in organs analyzed by FACS. A, Experimental design. B, Representative FACS analysis of indicated organs. Gating on CD8 T cells, numbers indicate
percentage of transferred cells. C, Total lymphocyte numbers isolated from indicated organs. D, Transferred Thy1.1
+ CD8
+ T cells from indicated organs.
Data from one representative experiment is shown, with n=2 control and n=3 FTY720 treated mice. (*p,0.05, ** p,0.01, and *** p,0.001).
doi:10.1371/journal.pone.0010973.g005
T Cells Re-Distribute to Lung
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e10973cells and enumerated them in organs. However, it must be
considered that T cell migration is a very dynamic process and our
analysis was limited to one time point (18hrs post-transfer). Earlier
or later times may have shown differences in organ distribution of
these transferred T cells. Nonetheless, our results demonstrated
preferential accumulation of both naı ¨ve and central memory T cell
populations in non-lymphoid organs of FtDKO mice (Figure 3).
This observation is in contrast to the main dogma that suggests
these cells do not enter non-lymphoid organs, but fits well with
alternatively proposed migration models that suggest T cells
continuously enter lymphoid and non-lymphoid organs
[44,45,46]. Moreover, we found that conditions that inhibit T
cell trafficking to the LN, and increase the proportion of T cells in
the blood, such as Ptx treatment and anti-CD62L blockade, also
result in increased naı ¨ve CD8 T cell trafficking to non-lymphoid
organs (Figure 4 and 6). In contrast, inhibition of T cell exit from
the LN by FTY720 agonism of S1P1, which drops the proportion
of T cells in the blood, significantly reduced the number of naı ¨ve
CD8 T cells in lung and liver (Figure 5 and 6). Similarly, transfer
of naı ¨ve CD4 T cells into anti-CD62L treated recipient mice or
FTY720 treated mice also showed alterations of CD4 T cell
numbers in the lung (S. Caucheteux and W.E. Paul, unpublished
observation). Taken together, these data suggest that when T cell
trafficking to LN is altered, this influences the concentration of T
cells in the blood that enter the spleen and non-lymphoid organs
such as the lung and liver. While this does not preclude the
possibility that additional changes in peripheral tissues of FtDKO
mice may also influence trafficking of T cells, it does suggest that
altered T cell trafficking to LNs is sufficient to cause increased T
cell accumulation in several organs.
Normal re-circulation of T cells to secondary lymphoid organs
such as LN, spleen, and mucosa associated lymphoid tissues such
as O-NALT, is thought to be important for T cell interaction with
stromal cells expressing IL-7 and other survival cytokines [47,48].
As noted above, there is controversy in the literature regarding
whether naı ¨ve T cells normally migrate into non-lymphoid organs.
Figure 6. Naı ¨ve T cell migration to non-lymphoid organs is influenced by T cell concentration in the blood. Proportions of transferred
naı ¨ve T cells in selectin ligand deficient mice (FtDKO), Gai signal disruption (Ptx), CD62L blockade, and FTY720 treated mice are shown. A, Total number
of transferred naı ¨ve CD8 T cells in CLN, MedLN, ILN, liver, and lung was calculated, and the percent of transferred naı ¨ve CD8 T cells in LNs versus non-
lymphoid organs is shown for each treatment group. B, The relationship of naı ¨ve CD8 T cells in the blood compared to naı ¨ve CD8 T cells in organs (LN
versus non-lymphoid organs). Concentration of naı ¨ve CD8 T cells in PBMCs was determined for each animal and the ratio of treatment versus control for
each treatment group is shown (R=1 for control, untreated group). Data is shown from 5 independent experiments for a total of n=28 mice.
doi:10.1371/journal.pone.0010973.g006
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and memory T cells enter non-lymphoid organs, and naı ¨ve T cells
do not normally enter these sites [8,44,49]. However, other studies
have reported that as part of the normal migratory pathway, naı ¨ve
T cells enter non-lymphoid organs including lung, but naı ¨ve T cell
residency time in these organs is short compared to effector/
memory T cells [34,35,36,45,50,51]. Recently published data has
shown that lung and liver are also sites of significant IL-7
production as measured by RNA message level [52]. Possibly,
naı ¨ve T cells that migrate into highly vascularized organs such as
liver and lung are able to receive sufficient IL-7 survival signals
that sustain them in these microenvironments. Moreover, several
recent papers have shown that T cells are capable of responding to
viral antigens in organs and T cells are not dependent on
trafficking to draining lymph node for priming [53,54,55]. Neo-
lymphoid aggregates or follicles have been described in both liver
and lung, and are proposed to be sites of potent T cell immune
responses [54,55].
The importance of elucidating mechanisms by which T cells, as
well as other inflammatory cells, migrate into and out of the lung is
underscored by the global health burden associated with lung
diseases including COPD, asthma, and lung metastasis. Our data
examining uninfected FtDKO mice revealed substantial increases
in naı ¨ve T cells in the lung, and uncovered a selectin ligand
independent pathway of T cell migration in the absence of lung
inflammation. Several years ago, another group published a study
describing selectin-independent mechanisms of trafficking to the
inflamed lung following Mycobacterium tuberculosis infection of
FtDKO mice [21]. Similar to our data, they showed that activated
CD8 T cell numbers were reduced in the lung early and late
following infection, but these mice were able to control the
infection comparable to WT mice [21]. However, the study’s
authors concluded that recruitment of effector T cells to lungs was
solely selectin-independent, and argued that the decreased
numbers they observed following infection was due to a delay in
priming of T cells. Since LCMV efficiently primes T cells in the
spleen, where we observed no defects in T cell migration, we
conclude that our observation of decreased Ag-specific CD8 T
cells in lung was likely due to the contribution of selectin ligands in
T cell homing to inflamed lung consistent with earlier work
[23,25,27]. However, our study is consistent with Schreiber et. al.
’s conclusion that substantial numbers of activated CD8 T cells are
able to migrate into the lung and peripheral organs in a selectin
ligand-independent manner [19,21].
Selectin mediated binding initiates the earliest step of lympho-
cyte extravasation by slowing lymphocyte rolling along HEVs. As
demonstrated, the loss of selectin ligand expression results in
profound impairment in T cell extravasation to LN [16].
However, for T cell entry to the lung parenchyma, it is possible
that physical slowing in the small capillaries of the lung is sufficient
for T cells to efficiently enter lung routinely as part of normal
migration [34,35,51]. Several studies have documented that the
normal diameter of a capillary in the lung is ,7 mm which
requires that larger leukocytes, such as lymphocytes and
granulocytes, undergo cytoskeletal rearrangement for cell defor-
mation and elongation in order to pass through pulmonary
capillary beds [40,56,57]. Otherwise, these cells become seques-
tered at these sites. If so, when the proportion of lymphocytes in
the blood increases, such as under inflammatory conditions, or
when T cell entry to the LN is blocked, T cell entry to the lung
may increase as T cells become trapped in the capillary bed, and
move into adjacent perivascular and interstitial compartments of
the lung. Thus, selectin-mediated binding likely enhances an
already effective entry process to the inflamed lung. Furthermore,
additional cell adhesion molecules expressed by effector and
effector memory T cells also enhance trafficking, as well as
retention, in peripheral organs such as lung [58,59]. The presence
of antigen and/or changes in chemokine expression in tissues
following microbial infection will also influence naı ¨ve T cell
migration/retention in non-lymphoid organs [60].
In summary, our data discovered that FtDKO mice had a
significant increase in naı ¨ve T cells in the lungs, and demonstrated
increased naı ¨ve and central memory T cell accumulation in non-
lymphoid organs. Furthermore, we observe an inverse relationship
between naı ¨ve T cell location in LN and non-lymphoid organs. By
inhibiting T cell entry to or exit from the LN, we show that the
ratio of naı ¨ve T cells in the blood is altered, and this influences the
number of naı ¨ve T cells that re-distribute to non-lymphoid organs.
In patients with leukocyte adhesion deficiency diseases, where
patients suffer from recurrent infections, including a significant
proportion of respiratory infections, altered leukocyte trafficking
may influence disease development in certain organs [61,62,63].
Proposed immunosuppressive therapies that target or alter
trafficking of T cells into or out of the LN should consider that
such treatments will likely influence the distribution of T cells in
blood, and consequently, increase T cell accumulation in non-
lymphoid organs, including the lung [64,65].
Materials and Methods
Mice and Immunizations
Fucosyltransferase IV and VII double knockout (FtDKO) mice
backcrossed at least 9 generations to C57BL/6 were originally
generated by Dr. John Lowe [16]. Mice were obtained from the
Consortium for Functional Glycomics (Scripps Research Institute,
La Jolla, CA) and bred in-house as homozygous double knockouts,
but breed poorly. Transgenic P14xThy1.1 mice were provided by
Dr. Rafi Ahmed (Emory Vaccine Center, Atlanta, GA) and bred
in-house. C57BL/6 (WT) mice were purchased from The Jackson
Laboratory. Memory P14xThy1.1 chimeric mice were generated
by adoptive transfer of 5610
5 total splenocytes from transgenic
P14xThy1.1 mice into C57BL/6 recipients and infected with
2610
5 pfu LCMV-Armstrong. FtDKO and C57BL/6 wildtype
control mice were immunized intraperitoneally (i.p) with 2610
5
pfu LCMV-Armstrong. All mice were maintained under specific
pathogen-free conditions at the University of Tennessee in
accordance with IACUC guidelines and used at age 2 to 6
months. All animals were handled in strict accordance with good
animal practice as defined by University of Tennessee IACUC
committee and all animal work was approved by the committee.
Naı ¨ve and Memory Cell Trafficking
Where indicated, MACS (Miltenyi Biotech, Auburn, CA)
purified naı ¨ve and memory P14xThy1.1 CD8 T cells (2610
6)
from the spleen were adoptively transferred into WT or FtDKO
recipient mice. Naı ¨ve cells were labeled with carboxyfluorescein
succinimidyl ester (CFSE) in order to differentiate transferred
naı ¨ve and memory P14xThy1.1 CD8 T cell populations. Equal
numbers of Ag-specific CD8 T cells were injected intravenously
(i.v.) via tail vein. In pertussis toxin (Ptx) inhibition experiments,
P14xThy1.1 splenocytes were pretreated with Ptx (Calbiochem,
Gibbstown NJ) or PBS for 90 minutes at 37uC [50] and 1610
6 Ptx
or PBS treated Ag-specific CD8 T cells were adoptively
transferred into WT recipient mice. For anti-CD62L experiments,
100 mg of MEL-14 (a-CD62L) blocking antibody (BioXcell, W.
Lebanon, NH) was injected i.v. into WT recipient mice. Four (4)
hours post treatment, 1610
6 P14xThy1.1 CD8 T cells were
injected i.v. into mice. In FTY720 experiments, 1610
6
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PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e10973P14xThy1.1 CD8 T cells were adoptively transferred into
recipient WT mice, followed by treatment with 1 mg/kg
FTY720 (Calbiochem) or water i.p. with treatment every 24 hrs
for 3 days total.
Organ Harvest, Flow Cytometry, and Histology
At indicated time points mice were sacrificed, organs were
perfused with 5 ml cold PBS, and tissues harvested for processing
as previously described [22,66]. Briefly, perfused organs were
minced, incubated with HBSS+ 1.3 mM EDTA solution for 30
minutes at 37uC, re-suspended in 225 U/ml type I collagenase for
60 minutes at 37uC, and cells were centrifuged using a Percoll
density gradient to isolate lymphocytes from the parenchyma.
Single cell suspensions were stained with D
bNP396-404 or
D
bGP33-41 tetramers, provided by the NIH Tetramer Facility
(Atlanta, GA), and mAbs (CD8, CD4, CD44, CD62L, Thy1.1,
Thy1.2) [67]. Total number of cells in bone marrow was
calculated by multiplying the number of cells from two femurs
67.9 [68,69]. Numbers of cells in PBMC are shown as per 10
6
cells. Monoclonal antibodies were purchased from BD (La Jolla,
CA). All samples were run on a FACSCalibur (BD Biosciences)
and analyzed with FlowJo software (Treestar). For histology, lungs
were infused with 1 mL of 50% OCT (Tissue Tek, Torrance, CA)
in PBS, embedded in OCT, and frozen on dry ice, and stored at
280uC. Serial sections were cut at 7 mm and stained with
hematoxylin and eosin using routine staining procedures. Lung
sections were also stained with biotinylated primary Ab, Thy1.2
(1:1500; BD Biosciences), followed by Alexa Fluor 568 conjugated
streptavidin (1:400; Invitrogen, Eugene, OR), and analyzed using
an epifluorescent microscope (Nikon Eclipse E600). For transfer
studies, to calculate the proportions of transferred cells in different
organs, total Thy1.1
+ CD8
+ T cells in indicated organs were
enumerated. The number of transferred cells in each tissue was
then divided by the total Thy1.1
+ CD8
+ cells in examined organs.
Statistical significance was determined using unpaired student t
tests where *indicates p,0.05, ** p,0.01, and *** p,0.001.
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